Brevia Health deepens vaccines expertise with Nick Lowen appointment

Brevia Health has deepened our vaccines expertise with the appointment of Nick Lowen as an Associate with over 30 years’ life sciences experience including serving as Vice President, Commercial Strategic Projects at GSK.  During his time at GSK, Nick successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, he oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.  Nick joins our senior team of advisers that include Gillian Leng CBE (former CEO, NICE), Jonathan Mogford (former Director of Policy, MHRA) and Mike Thompson MBE (former CEO, ABPI).

Nick trained as a pharmacist and began his career in the NHS.  Before joining the Biopharma industry, he was one of the UK’s first regional NHS Pharmaceutical advisers.

He joined GSK in 1997 where he worked for over 25 years and held a number of senior leadership roles.  During this period, he successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, Nick oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.

In addition to Vaccines, Nick has therapeutic experience in Neurology, Dermatology, Anti-infectives, Respiratory, Oncology and specialist medicines.

Nick has a passion for delivering marketing and sales excellence across Global, EU and UK Pharmaceutical markets through launching innovative products, life cycle management and building market access.  He has a strong track record managing teams to create and deliver strategic business change in Pharma, including managing the transition to outsource operations in multiple countries, creating business development opportunities, and negotiating and concluding significant business deals.

 

BREVIA HEALTH PROVIDES STRAIGHTFOWARD PUBLIC AFFAIRS AND PUBLIC RELATIONS SUPPORT TO BUSINESSES AND CHARITIES OPERATING IN THE HIGHLY REGULATED UK HEALTHCARE SECTOR

Discover how Brevia can help you and your organisation by viewing our Health services or contacting the Brevia Team on 020 7091 1650 or emailing us at contact@brevia.co.uk

 

 

 

 

 

LATEST NEWS

Energy

10 key events in energy in 2025

As a year marked by long-anticipated decisions and significant policy signals draws to a close, Brevia Energy takes a look back at developments and decisions that shaped the UK energy landscape in 2025.

Read More »
Brevia

Nuclear Regulatory Taskforce Report – Key Takeaways

Last month, the Nuclear Regulatory Taskforce published its final report. Although the UK is one of 33 countries pledging to triple its nuclear capacity by 2050, the Taskforce warns that the current system risks slowing delivery at a time when global competitors are accelerating. Brevia Energy explores the key takeaways from the Report.

Read More »
Health

Who is the new CEO of the National Institute for Care and Excellence?

On 16 December 2025, the National Institute for Care and Excellence (NICE) announced that Professor Jonathan Benger CBE will be the organisation’s next Chief Executive, from Friday 19 December 2025. Professor Benger takes up his new role at a pivotal moment, as NICE plays a central part in delivering the Government’s 10 Year Health Plan for the NHS.

Read More »